Skip to main content
NCBI home page
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Feb 10.
Published in final edited form as: Dev Neurosci. 2025 Feb 10;47(6):458–467. doi: 10.1159/000544063

GROWTH DIFFERENTIATION FACTOR 15 KNOCKOUT MICE ARE PROTECTED FROM NEONATAL HYPOXIC-ISCHEMIC INJURY IN A SEX DEPENDENT MANNER

Jeremy R Herrmann 1,2, Patrick M Kochanek 3, Vincent A Vagni 3, Keri A Janesko-Feldman 3, Jason P Stezoski 3, Travis C Jackson 4
PMCID: PMC12335607  NIHMSID: NIHMS2055646  PMID: 39929157

Abstract

Introduction:

Neuroinflammation plays a critical role in tissue injury and repair after neonatal hypoxic-ischemic (HI) brain injury and varies by sex. Growth differentiation factor-15 (GDF-15) is a cytokine released by macrophages during inflammation and is upregulated after brain ischemia. We examined the impact of GDF-15 knockout (KO) on volume loss and the combined microglia/macrophage response in the Rice Vannucci model of neonatal HI injury.

Methods:

Male and female wild-type (WT) Gdf15+/+, heterozygous Gdf15nuGFP-CE/+ (Het), and homozygous Gdf15nuGFP-CE/nuGFP-CE (KO) mice were bred at the University of Pittsburgh. Postnatal day 9–11 mice were randomized to sham procedure or unilateral common carotid artery ligation followed by exposure to 8% O2 for 25min. Pups were subsequently genotyped and survived for 14 days before sacrifice. Lesion volume and number of ionized calcium-binding adapter molecule 1 (Iba-1) positive cells were quantified.

Results:

Injured male KO pups had decreased hemispheric and hippocampal lesion volume vs. injured male WT pups. Injured male Het pups demonstrated an intermediate phenotype. In males, the number of Iba-1 positive cells correlated with extent of tissue loss. In females, the extent of volume loss and Iba-1 cell counts post-injury did not vary by genotype.

Conclusion:

GDF-15 exerts a sex-dependent deleterious effect on lesion volume in a neonatal HI model. Future work should identify how GDF-15 mediates different neuroinflammatory responses between sexes, establish if brain-secreted vs. peripherally-derived GDF-15 mediates the pro-injury phenotype that was inhibited in male KOs, and test if therapeutic inhibition of GDF-15 signaling is a novel treatment for neonatal HI brain injury.

Keywords: Macrophage inhibitory cytokine-1, Rice Vannucci, brain injury, neuroinflammation, neonatal encephalopathy, asphyxia, stroke

INTRODUCTION

Neuroinflammation has beneficial and detrimental effects on brain tissue survival in resuscitated newborns with hypoxic-ischemic (HI) neonatal encephalopathy (NE)[1]. Sex assigned at birth robustly impacts the balance between the opposing effects of neuroinflammation on the brain. Specifically, males have a greater number of activated microglia (MG) and infiltrating leukocytes and macrophages in the injured brain and increased markers of histological damage vs. females in animal models of HI NE[1, 2]. These findings agree with clinical observations that male newborns with birth asphyxia have increased risk of unfavorable outcome[3].

Experimental immune-modulating therapies in NE models also effect neurological outcomes differently in males vs. females. For instance, MG depletion increased brain tissue volume loss in males but not in females[4]. Gene knockout (KO) studies in mice are still required to elaborate on this finding by elucidating the role that individual neuroinflammatory protein mediators have on brain tissue injury in both sexes, particularly in neonatal HI models that recapitulate the unique molecular and physiological state of newborns.

The hormone growth differentiation factor 15 (GDF-15, a.k.a. macrophage inhibitory cytokine-1 [MIC-1]) is released from macrophages during inflammation and promotes survival in animal models of severe infection—a condition in which enhanced inflammation can be beneficial[5–7]. Focal and global ischemia can also increase GDF-15 levels in the brain and organs outside of the CNS[8, 9]. Further, serum GDF-15 levels are markedly increased after asphyxial cardiac arrest in infants and children and associated with unfavorable outcome[10, 11]. But whether GDF-15 is detrimental or beneficial in pediatric brain injury remains to be defined. In adult mice, blocking systemic GDF-15 activity with genetic KO did not affect infarct volume after middle cerebral artery occlusion (MCAO) stroke, although female mice were not investigated[9]. Much remains to be learned about GDF-15 in the adult or developing female brain; the recent successful translation of GDF-15 inhibitors for clinical use highlights the timeliness of understanding GDF-15’s role in brain injury[12].

Here we examined the effect of GDF-15 KO on 14 day post-insult hemispheric and hippocampal lesion volume, and on ionized calcium-binding adaptor molecule 1 (Iba-1) staining, in male and female post-natal day (PND) 9–11 mice in the Rice-Vannucci model of developmental unilateral forebrain HI, with strict temperature control to normothermia[13]. Our findings reveal a detrimental effect of GDF-15 in murine neonatal HI in males but not females. A concordant enhanced MG/macrophage response to HI in male vs. female WT mice suggests a sex-dependent deleterious neuroinflammatory role of GDF-15.

METHODS

Animals.

C57BL/6-Gdf15tm1(cre/ERT2)Amc/J mice (a.k.a Gdf15nuGFP-CE) were purchased from Jackson Laboratory (Stock #034497). The design and validation of these mice was previously described[14]. Mice were bred at the University of Pittsburgh in a pathogen-free housing facility managed by the Division of Laboratory Animal Resources. All studies were approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh (Protocol #22071487). Euthanasia protocols followed American Veterinary Medical Association guidelines. Mice were maintained on a 12h light cycle and given free access to food and water. To maximize rigor of the experimental design, mice were genotyped after they recovered from injury by a second technician blinded to treatment group. Tissue genotyping was performed by standard PCR in two different reactions using JAX Protocol 37350 with adaptations. The mutant Cre amplicon (200bp band) was detected using forward and reverse primers: 5’-GCGGTCTGGCAGTAAAAACTATC-3’ and 5’-GTGAAACAGCATTGCTGTCACTT-3’. The wild-type (WT) GDF15 amplicon (352bp band) was detected using forward and reverse primers: 5’-TGTTAGGCCTGGTTTGAAGG-3’ and 5’-CTGGGTGGATGGATTGTGT-3’. WT, heterozygote (Het) and KO mice were included in this analysis. Because investigators were blinded to genotype before injury, group sizes were unevenly distributed across genotypes. Investigators were not blinded to sex. We collected and stored brains in formaldehyde and targeted n=6 for all groups, based on our prior work in male mice[13]. We processed up to the first 6 brains in the order that they were collected for histology for each group. In total, 70 pups were used for this study.

HI Injury Model.

PND 9–11 mice underwent sham or HI procedures as we reported[13]. In brief, isoflurane anesthetized pups (3% induction and 1.5–3% maintenance in a 2:1 mixture of N2O/O2) were weighed and core body temperature (Tb) was monitored during surgery (sham or common carotid artery [CCA] occlusion) via a neonatal rectal probe (Physitemp). Tb was maintained to ~36°C, which is normothermic at this age in mice[13]. Post-surgical temperature was maintained by intermittent measurement with a pediatric infrared thermometer (IRT, Braun Healthcare US). The right CCA was ligated and cut. The incision was closed with 3M Vetbond Tissue Adhesive (Maplewood) and Bupivacaine (0.25%) applied to the wound. Mice advanced through the protocol in blocks of 4. A second technician working in tandem maintained pup temperatures at ~36°C post-surgery. Pups were then returned to the foster dam for 1h. They were then placed inside an acrylic hypoxia chamber glove box (Coy; Grass Lake, MI). The hypoxia exposure time was 25 min (8% O2/92% N2). Tb was monitored via IRT during hypoxia and maintained at ~36°C. Shams received surgery without CCA ligation and were maintained at normoxia and normothermia for 25 min. After hypoxia or normoxia, Tb was maintained at ~36 °C in room air for 2 h:5 min on a benchtop with lamps and heating blankets, and temperature recorded every 15min.

Lesion Volume Analysis:

At 14d post-insult, mice were transcardially perfused with heparinized saline followed by 10% neutral buffered formalin. Whole fixed brains were embedded in paraffin. Sections were taken every 0.5-mm from posterior to anterior and stained with Hematoxylin and Eosin. Hemispheric area was measured on each slide by a technician blinded to group and added for total volume (MCID Analysis software, St. Catherines, Ontario). Hippocampal area was also quantified on slides with a visible hippocampus (~2-mm distance in total) and the volume was calculated. To normalize for brain volume changes of technical (e.g. embedding) or genetic (e.g., GDF-15 expression) origin, lesion volume loss was calculated as a percentage of the contralateral side. In our prior work, we demonstrated consistent lesion volume at 14d with this HI injury model, and differences at this timepoint are thought to reflect durable neuroprotection[15, 13].

Immunohistochemistry:

Sections from formalin fixed paraffin embedded tissue were deparaffinized, rehydrated and underwent an Antigen Retrieval Process (Antigen Decloaker, Biocare Medical, Pacheco, CA) as previously described [16]. Endogenous peroxidases were blocked in 0.3% H2O2 for 30 min then tissue was blocked with 3% normal goat serum (Vector, Burlingame, CA, USA) in TBS containing 0.25% Triton X for 1h at room temperature. Sections were incubated overnight containing an antibody for the MG/macrophage marker Iba-1 (Abcam, Cat. 178846, 1:1,000)[17]. The sections were then incubated for 1h with biotinylated anti-rabbit secondary antibody followed by the avidin-biotin complex for 1h (ABC Kit, Vector) and stained with 3,3′-diaminobenzidine (DAB, Vector). Slides were imaged using a Nikon Eclipse 90i microscope [16]. The number of Iba-1 positive (Iba-1+) objects were counted using QuPath [18]. Regions of interest were identified in scanned slides and the threshold function was used to identify IbA1+ staining. A size and signal intensity threshold was established to discriminate between artifact and cellular staining.

Statistical Analysis:

Original or transformed data (Box-Cox or aligned rank transformation/ART method[19]) that were normally distributed and homoscedastic were analyzed using two-way ANOVA. Post-hoc testing was done using Tukey’s multiple comparison test. For pairwise comparisons on ART transformed datasets, the original data were again transformed but with the ART-Contrasts tool (ART-C [20]). Then the transformed data were analyzed with a standard one-way-ANOVA and post-hoc significance detected with the Tukey’s multiple comparison test. Data were significant at p<0.05. Cubic regression was performed to assess the correlation between Iba-1+ counts and lesion volume. Statistical analysis was performed using Prism10 (GraphPad Software, LLC).

RESULTS

In males there was a significant interaction between insult and genotype on hemispheric volume at 14d post-insult (P=0.014). In addition, insult alone had a significant effect on hemispheric volume (P<0.001) (shown in Fig. 1). Specifically, on post-hoc testing male WT mice had significant volume loss in the injured hemisphere post HI vs. male shams (WT HI median 21.31% Interquartile Range [3.42–55.83] vs. WT Sham 0.85% [−0.28–2.58], P<0.01). In contrast, hemispheric volume loss in injured male KO mice did not differ vs. male KO sham (KO HI 1.44% [−0.17–4.59] vs KO Sham 1.70% [−0.89–4.13], P>0.99). Het males had an intermediate phenotype after injury (Het HI 5.62% [2.68–12.68] vs. Het Sham 1.80% [−2.99–3.09], P=0.07).

Fig. 1.

Fig. 1.

Open in a new tab

Impact of neonatal hypoxic-ischemic (HI) injury and genotype on lesion volume by sex. Post-natal day 9–11 mice underwent unilateral carotid artery ligation followed by exposure to 8% oxygen for 25 min. Lesion volume was calculated as a percent loss vs. the contralateral side. Data were transformed by aligned rank test and then analyzed by two-way ANOVA with post-hoc Tukey’s test. Visualized data is before transformation. A) Hemispheric lesion volume in males after HI vs. sham by genotype. B) Hemispheric lesion volume in females after HI vs sham by genotype. C) Hippocampal lesion volume in males after HI vs sham by genotype. D) Hippocampal lesion volume in females after HI vs sham by genotype. NS=non-significant, *= P<0.05, **=P<0.01, ***= P<0.001, ****= P<0.0001. WT = wild-type; Het = heterozygote; KO = knockout; HI = hypoxia-ischemia; NS = non-significant.

In females there was no effect of genotype (P=0.516) or interaction between genotype and injury (P=0.588). But insult alone had a significant effect on hemispheric volume (P<0.0001). HI in females produced a milder insult as determined by the magnitude of hemispheric tissue loss. On post-hoc testing injured female WT and KO mice still had significant tissue loss after HI vs. sham groups (WT HI 4.61% [4.41–7.59] vs. WT Sham 1.89% [0.44–2.84], P<0.01, KO HI 5.16% [4.12–6.72] vs. KO Sham 2.55% [0.55–3.29], P<0.05). And there was no significant hemispheric volume loss in female Het mice vs. shams after HI (Het HI 3.13% [2.16–8.15] vs. Het Sham 1.77% [−0.17–4.49], P=0.54).

Regarding hippocampal volume loss in males there was a significant effect of insult (P<0.0001), and a trend with genotype (P=0.070), but no interaction between genotype and insult (P=0.215) (shown in Fig. 1). On post-hoc testing injured WT, Het, and KO males had significant hippocampal volume loss vs. their respective sham groups (WT HI 65.53% [17.02–100.00] vs. WT Sham 4.50% [−3.54–8.95] P<0.0001, Het HI 24.98% [18.79–59.27] vs. Het Sham 0.44% [−4.36–6.33], P<0.001, KO HI 31.85% [12.32–35.69] vs. KO Sham −3.73% [−9.74–8.11], P<0.001). In females there was an effect of insult (P<0.0001) but not genotype (P=0.882) or the interaction between genotype and insult (P=0.585) (shown in Fig. 1). On post-hoc testing injured WT, Het, and KO also had significant hippocampal volume loss vs. respective sham groups (WT HI 18.53% [15.06–26.01] vs. WT Sham 5.47% [−2.87–9.93], P<0.05, Het HI 23.07% [10.12–44.94] vs. Het Sham 1.35% [−0.85–7.65], P<0.01, KO HI 32.26% [12.19–36.38] vs. KO Sham 2.75% [0.24–6.80], P<0.01).

Next, we examined Iba-1+ cell counts in the injured hemisphere and hippocampus. In males there was a trend for insult (P=0.081) to increase and GDF-15 KO genotype to decrease (P=0.078) the number of Iba-1+ cells in the injured hemisphere, but no interaction between the 2 factors (P=0.929) (shown in Fig. 2). In females there was no significant effect of injury (P=0.474), genotype (P=0.590) or for their interaction (P=0.898) (shown in Fig. 2).

Fig. 2.

Fig. 2.

Open in a new tab

Impact of hypoxic-ischemic (HI) injury and genotype on microglial counts by sex. Post-natal day 9–11 mice underwent unilateral carotid artery ligation followed by exposure to 8% oxygen for 25 min. Tissue was stained for Ionized Ca+2-binding adapter protein 1 (Iba-1), which was normalized by tissue area analyzed. If non-normally distributed, data underwent Box-Cox transformation and then analyzed by two-way ANOVA with post-hoc Tukey’s test. Visualized data is before transformation. A) Hemispheric Iba-1+ counts in males after HI vs. sham by genotype. B) Hemispheric Iba-1+ counts in females after HI vs. sham by genotype. C) Hippocampal Iba-1+ counts in males after HI vs. sham by genotype. D) Hippocampal Iba-1+ counts in females after HI vs. sham by genotype. Iba-1 = ionized calcium-binding adaptor molecule; WT = wild-type; Het = heterozygote; KO = knockout; HI = hypoxia-ischemia. NS=non-significant, *= P<0.05, **=P<0.01.

Regarding the hippocampus, brain atrophy was so extensive in 2 WT mice that it was missing and thus unable to be included for Iba 1+ analysis. In males, there was a significant effect of insult (P<0.001), but not genotype (P=0.237) or for the interaction between genotype and insult (P=0.196) (shown in Fig. 2). On post-hoc testing, injured male KOs had a significant increase in Iba-1+ cells in the hippocampus after injury vs. KO shams which was not seen in WTs or Hets (WT HI 0.56 Iba1+/mm2 [0.41–1.57] vs. WT Sham 0.51 [0.46–0.54] P=0.959, Het HI 0.52 [0.49–0.91] vs. Het Sham 0.42 [0.33–0.52], P=0.204, KO HI 0.61 [0.48–0.83] vs. KO Sham 0.35 [0.29–0.40], P<0.05). In females, there was a trend for an effect of genotype on Iba-1+ cells (P=0.077), but not for insult (P=0.706) or for the interaction between genotype and insult (P=0.399) (shown in Fig. 2).

In males there was a strong correlation between hemispheric and hippocampal volume loss and Iba-1+ cell counts (R2 hemisphere = 0.976, R2 hippocampus = 0.853, shown in Fig. 3). In females, correlations between hemispheric and hippocampal lesion volume and Iba-1+ cell counts were not seen (R2 hemisphere = 0.365, R2 hippocampus = 0.275, shown in Fig. 3).

Fig. 3.

Fig. 3.

Open in a new tab

Correlation between lesion volume and Iba-1+ cell counts across injured mice. Curve was identified by third order polynomial fit. A) Male hemispheric lesion volume vs. Iba-1+ counts. B) Male hippocampal lesion volume vs Iba-1+ counts. C) Female hemispheric lesion volume vs. Iba-1+ counts. D) Female hippocampal lesion volume vs. Iba-1+ counts. Black dots represent GDF-15 KO mice, dark gray represent GDF-15 heterozygote mice and light gray represent WT mice. Iba-1 = ionized calcium-binding adaptor molecule.

DISCUSSION

We report that total GDF-15 KO decreased hemispheric and hippocampal volume loss in male neonatal mice after HI brain injury and was associated with decreased Iba-1+ cells in both brain regions, vs. injured male WT mice. Trends toward reduced histological markers of damage were also seen in injured male Het mice but our study was not powered to test for a possible gene dose effect. In contrast, neither hemispheric nor hippocampal volume, nor Iba-1 staining, differed in injured female GDF-15 KO, Het, or WT mice. Our data suggest a detrimental role of GDF-15 for the male brain in neonatal HI and the possible involvement of MG/macrophages linked with that sex dependent effect.

Prior studies on sex-differences in the Rice Vannucci model show that male mice have larger infarct volume vs. females given equivalent insult parameters[1, 21]. Greater tissue loss in males is unlikely to be explained by the levels of sex hormones since there are no differences in testosterone and estrogen levels post-injury[1, 21]. Intrinsic sex differences in mediators of neuroinflammation could, however, underlie the divergence in tissue loss. Prior studies showed that male pups had higher numbers of MG at early post-natal ages and that male rodents had more activated MG vs. females at 3 d post-neonatal HI[1]. Here we found that male WT shams had higher Iba-1+ counts vs. WT females, and that injured WT males had higher Iba-1+ counts vs. injured females. Moreover, hemispheric tissue loss was greater in injured males. Thus, both baseline sex differences in Iba-1 and the response to injury were recapitulated here in the Rice Vannucci model.

GDF-15 KO was neuroprotective in males but not in females, consistent with other studies exploring other immune-modulatory approaches to increase brain tissue survival in this model in both sexes. For instance, peripheral myeloid cell depletion decreased brain tissue loss in males, but not females at 14 d post-insult[22]. In contrast, supporting beneficial effects of MG in this model, pre-injury MG depletion increased damage, lesion volume, and number of TUNEL positive cells in brain in males but not females[4]. It is unclear why immune modulation in females provides less benefit, or conversely does not aggravate damage. It could be that neuroinflammation is less pronounced after neonatal HI in females—providing less of a target to inhibit in settings with detrimental effects, or greater opportunities to enhance benefit. Furthermore, GDF-15 requires the GDNF Family Receptor Alpha Like (GFRAL) receptor to trigger downstream pathways[23, 24]. Sex differences have also been reported in GFRAL KO mice–such as impairing mitochondrial stress induced nighttime food intake in males but not in females[25].

A variety of non-CNS conditions also increase GDF-15 expression[26, 6, 14, 27, 28]. Septic patients have increased serum GDF-15 levels regardless of the infectious agent and in models of viral or bacterial sepsis, blockade of GDF-15 signaling increases mortality[6]. This supports a beneficial effect of GDF-15 on survival in sepsis – contrasting our findings in neonatal HI in the brain without infection. Benefit from greater inflammation might be expected in models of infection. Age-related differences might also contribute to the divergent responses. Brain microvascular endothelial cells increase GDF-15 expression in E. coli meningitis, but the role of GDF-15 in CNS infection remains unclear[29].

GDF-15 increases in multiple tissues post-ischemia, including the brain, myocardium, and kidney[26, 9, 14]. Regarding brain, in MCAO in adult mice, GDF-15 expression increases after injury in the cortex and hippocampus, but KO of GDF-15 expression did not impact neurologic score or infarct volume vs. WT[9]. This contrasts our results suggesting that age may be critical to understand the role of GDF-15 in mediating HI brain injury. It is unclear if there is a GDF-15 switch in the neonatal period, as seen in several other key mechanisms that have divergent effects on brain tissue survival after HI in adults vs. newborns[30–32].

GDF-15 is a member of the TGF-β cytokine family and impacts the immune response to injury[6]. In a traumatic spinal cord injury (SCI) model in adult female mice, consistent with our data, GDF-15 KO reduced infiltrating macrophages. GDF-15 overexpression increased macrophage accumulation post-injury; however, it improved functional motor outcome[33]. GDF-15 is secreted by Schwann cells, and naïve GDF-15 KO mice have progressive loss of motor neurons in the spinal cord and motor deficits as they age[34]. Thus, it is unclear if GDF-15 overexpression improved functional outcomes in SCI by targeting neuroinflammation or rather neurotropic support of spinal axons. In contrast, in myocardial ischemia in adult male mice, GDF-15 inhibits β2 integrin activation on polymorphonuclear leukocytes (PMNs), reducing their recruitment into the myocardium. In that model, GDF-15 KO increased mortality from 35% to 81%[26]. A gene dose effect on mortality was also seen. Thus, there are important but conflicting roles of the effect of GDF-15 on inflammatory cell accumulation that depend on the tissue, the inflammatory cells involved, the type of insult, developmental age, and sex.

Given GDF-15’s implicated role in the immune response, we examined the number of Iba-1+ cells as a marker of combined activated MG/macrophage accumulation in the injured hemisphere and hippocampus[35, 6, 36]. In males, we found higher hippocampal Iba-1+ counts after HI with a similar trend in hemispheric data. Although sample size limited our statistical power, we saw a trend towards high Iba-1+ counts post-HI that differed across genotype in males. Iba-1+ counts were not affected after HI or by genotype in females. This suggests that the impact of GDF-15 on neuroinflammation varies by sex, with an increased MG/macrophage response and exacerbation of injury in male neonatal WT post-HI. Future studies should test whether targeted GDF-15 blockade is a therapeutic opportunity in males in neonatal HI models[6].

In addition to the impact on the inflammatory response, GDF-15 KO may have more systemic effects on animal development. However, prior reports examining GDF-15 KO vs. WT mice did not demonstrate any alterations in cardiovascular physiology or other major abnormalities[8, 34]. Although one report noted that adult female GDF-15 KO animals had significant weight gain, in our study there were no differences in pre-injury weights across genotypes in neonates[34]. Nevertheless, there remains a possibility that genotypic differences in extra-cerebral or non-inflammatory factors may have influenced the response to HI.

Once animals mature into adulthood, GDF-15 may transition to a neuroprotectant. In a SCI model, GDF-15 inhibited ferroptotic neuronal death in adult male mice via effects on Keap1-Nrf2[37]. GDF-15 is also directly neuroprotective in dopaminergic neurons after application of the neurotoxin 6-hydroxydopamine in vitro[38]. Age-dependent expression of GFRAL could impact effects of GDF-15 and based on our data, this question merits investigation. While GFRAL was originally thought to be restricted to a small area of the brainstem, recent work suggests that it may be expressed more widely in brain, particularly in developmental animals[23, 39, 40]. Finally, activation of GFRAL-expressing neurons in adult animals can induce hypothermia and alter neuronal metabolism[41]. This may also differ in developmental animals.

Limitations of our study include relatively small group sizes. To minimize the risk of bias, we did not genotype mice until after injury, limiting our ability to maximize group sizes within any given litter. Iba-1 staining also does not characterize the phenotype of MG activation. MG have pleiotropic and sex dependent effects in the brain[35, 42], and future studies should seek to characterize whether GDF-15 impacts MG phenotype. We could not meaningfully characterize effects of GDF-15 KO on accumulation of PMNs in our study, given that outcome assessment was limited to 14 d post HI. Future studies should thus examine temporal effects on acute and chronic neuroinflammation and the functional and behavioral impacts of our histological findings.

We conclude that GDF-15 exerts a sex-dependent increase in lesion volume in a neonatal encephalopathy model. The increased injury seen in WT vs KO males is associated with an increased MG/macrophage response. Future work should aim to identify how GDF-15 mediates the increase in injury and the differing inflammatory response between the sexes and test whether GDF-15 blockade, as used clinically for other indications, is a novel therapeutic target in neonatal encephalopathy in males [12].

Funding:

This work was supported by NIH/NINDS grant R01NS105721 to T.C.J., by a Lloyd Reback Family Gift, Laerdal Foundation for Acute Medicine grant, Zoll Foundation grant, and T32 (2T32HD040686) to J.R.H., and by the Ake N. Grenvik Chair in Critical Care Medicine to P.M.K. None of the funders had a role in the study design, execution, analysis, manuscript conception, planning, writing or decision to publish.

Footnotes

DECLARATIONS:

Ethics Approval: All studies were approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh (Protocol #22071487).

Competing Interests: The authors report no competing interests.

Consent for publication: Not applicable

Availability of Data and Materials:

All data generated or analyzed during this study are included in this published article. Further inquiries can be directed to the corresponding author.

REFERENCES

  • 1.Mirza MA, Ritzel R, Xu Y, McCullough LD, Liu F. Sexually dimorphic outcomes and inflammatory responses in hypoxic-ischemic encephalopathy. J Neuroinflammation. 2015. Feb 20;12:32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Brandt MJV, Nijboer CH, Nessel I, Mutshiya TR, Michael-Titus AT, Counotte DS, et al. Nutritional Supplementation Reduces Lesion Size and Neuroinflammation in a Sex-Dependent Manner in a Mouse Model of Perinatal Hypoxic-Ischemic Brain Injury. Nutrients. 2021. Dec 30;14(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chalak LF, Pruszynski JE, Spong CY. Sex Vulnerabilities to Hypoxia-Ischemia at Birth. JAMA Netw Open. 2023. Aug 1;6(8):e2326542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tsuji S, Di Martino E, Mukai T, Tsuji S, Murakami T, Harris RA, et al. Aggravated brain injury after neonatal hypoxic ischemia in microglia-depleted mice. J Neuroinflammation. 2020. Apr 11;17(1):111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Jung SB, Choi MJ, Ryu D, Yi HS, Lee SE, Chang JY, et al. Reduced oxidative capacity in macrophages results in systemic insulin resistance. Nat Commun 2018. Apr 19;9(1):1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Luan HH, Wang A, Hilliard BK, Carvalho F, Rosen CE, Ahasic AM, et al. GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance. Cell. 2019. Aug 22;178(5):1231–44 e11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Patsalos A, Halasz L, Medina-Serpas MA, Berger WK, Daniel B, Tzerpos P, et al. A growth factor-expressing macrophage subpopulation orchestrates regenerative inflammation via GDF-15. J Exp Med 2022. Jan 3;219(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 2006. Feb 17;98(3):351–60. [DOI] [PubMed] [Google Scholar]
  • 9.Schindowski K, von Bohlen und Halbach O, Strelau J, Ridder DA, Herrmann O, Schober A, et al. Regulation of GDF-15, a distant TGF-beta superfamily member, in a mouse model of cerebral ischemia. Cell Tissue Res 2011. Feb;343(2):399–409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Herrmann JR, Fink EL, Fabio A, Au AK, Berger RP, Janesko-Feldman K, et al. Serum levels of the cold stress hormones FGF21 and GDF-15 after cardiac arrest in infants and children enrolled in single center therapeutic hypothermia clinical trials. Resuscitation. 2022. Mar;172:173–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Herrmann JR, Jackson TC, Fabio A, Clark RSB, Berger RP, Janesko-Feldman KL, et al. Association of Growth Differentiation Factor-15 With Event Cause and Cardiovascular Failure After Pediatric Cardiac Arrest in a Multi-Institutional Trial. J Am Heart Assoc 2023. Jul 25:e029972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Groarke JD, Crawford J, Collins SM, Lubaczewski S, Roeland EJ, Naito T, et al. Ponsegromab for the Treatment of Cancer Cachexia. The New England journal of medicine. 2024. Sep 14. [DOI] [PubMed] [Google Scholar]
  • 13.Jackson TC, Herrmann JR, Garman RH, Kang RD, Vagni VA, Gorse K, et al. Hypoxia-ischemia-mediated effects on neurodevelopmentally regulated cold-shock proteins in neonatal mice under strict temperature control. Pediatr Res 2022. Feb 19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Liu J, Kumar S, Heinzel A, Gao M, Guo J, Alvarado GF, et al. Renoprotective and Immunomodulatory Effects of GDF15 following AKI Invoked by Ischemia-Reperfusion Injury. J Am Soc Nephrol 2020. Apr;31(4):701–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bond A, Jones NM, Hicks CA, Whiffin GM, Ward MA, O’Neill MF, et al. Neuroprotective Effects of LY379268, a Selective mGlu2/3 Receptor Agonist: Investigations into Possible Mechanism of Action In Vivo. The Journal of Pharmacology and Experimental Therapeutics. 2000;294(3):800–09. [PubMed] [Google Scholar]
  • 16.Simon DW, Rogers MB, Gao Y, Vincent G, Firek BA, Janesko-Feldman K, et al. Depletion of gut microbiota is associated with improved neurologic outcome following traumatic brain injury. Brain Res 2020. Nov 15;1747:147056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Köhler C Allograft inflammatory factor-1/Ionized calcium-binding adapter molecule 1 is specifically expressed by most subpopulations of macrophages and spermatids in testis. Cell Tissue Res 2007. Nov;330(2):291–302. [DOI] [PubMed] [Google Scholar]
  • 18.Bankhead P, Loughrey MB, Fernandez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Sci Rep 2017. Dec 4;7(1):16878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wobbrock JO, Findlater L, Gergle D, Higgins JJ. The aligned rank transform for nonparametric factorial analyses using only anova procedures. Proceedings of the SIGCHI Conference on Human Factors in Computing Systems. Vancouver, BC, Canada: Association for Computing Machinery; 2011. p. 143–46. [Google Scholar]
  • 20.Elkin LA, Kay M, Higgins JJ, Wobbrock JO. An Aligned Rank Transform Procedure for Multifactor Contrast Tests. The 34th Annual ACM Symposium on User Interface Software and Technology. Virtual Event, USA: Association for Computing Machinery; 2021. p. 754–68. [Google Scholar]
  • 21.Al Mamun A, Yu H, Romana S, Liu F. Inflammatory Responses are Sex Specific in Chronic Hypoxic-Ischemic Encephalopathy. Cell Transplant 2018. Sep;27(9):1328–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Smith PLP, Mottahedin A, Svedin P, Mohn CJ, Hagberg H, Ek J, et al. Peripheral myeloid cells contribute to brain injury in male neonatal mice. J Neuroinflammation. 2018. Oct 30;15(1):301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hsu JY, Crawley S, Chen M, Ayupova DA, Lindhout DA, Higbee J, et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 2017. Oct 12;550(7675):255–59. [DOI] [PubMed] [Google Scholar]
  • 24.Mullican SE, Lin-Schmidt X, Chin CN, Chavez JA, Furman JL, Armstrong AA, et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med 2017. Oct;23(10):1150–57. [DOI] [PubMed] [Google Scholar]
  • 25.Igual Gil C, Coull BM, Jonas W, Lippert RN, Klaus S, Ost M. Mitochondrial stress-induced GFRAL signaling controls diurnal food intake and anxiety-like behavior. Life Sci Alliance. 2022. Nov;5(11). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kempf T, Zarbock A, Widera C, Butz S, Stadtmann A, Rossaint J, et al. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat Med 2011. May;17(5):581–8. [DOI] [PubMed] [Google Scholar]
  • 27.Patel AR, Frikke-Schmidt H, Bezy O, Sabatini PV, Rittig N, Jessen N, et al. LPS induces rapid increase in GDF15 levels in mice, rats, and humans but is not required for anorexia in mice. Am J Physiol Gastrointest Liver Physiol 2022. Feb 1;322(2):G247–G55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Reyes J, Yap GS. Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis. J Immunol 2023. Jan 1;210(1):5–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Yang R, Qu X, Zhi S, Wang J, Fu J, Tan C, et al. Exosomes Derived from Meningitic Escherichia coli-Infected Brain Microvascular Endothelial Cells Facilitate Astrocyte Activation. Mol Neurobiol 2024. Feb 19. [DOI] [PubMed] [Google Scholar]
  • 30.Ditelberg JS, Sheldon RA, Epstein CJ, Ferriero DM. Brain injury after perinatal hypoxia-ischemia is exacerbated in copper/zinc superoxide dismutase transgenic mice. Pediatr Res 1996. Feb;39(2):204–8. [DOI] [PubMed] [Google Scholar]
  • 31.Chan PH, Kawase M, Murakami K, Chen SF, Li Y, Calagui B, et al. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci 1998. Oct 15;18(20):8292–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wu C, Sun D. GABA receptors in brain development, function, and injury. Metab Brain Dis 2015. Apr;30(2):367–79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Hassanpour Golakani M, Mohammad MG, Li H, Gamble J, Breit SN, Ruitenberg MJ, et al. MIC-1/GDF15 Overexpression Is Associated with Increased Functional Recovery in Traumatic Spinal Cord Injury. Journal of neurotrauma 2019. Dec 15;36(24):3410–21. [DOI] [PubMed] [Google Scholar]
  • 34.Strelau J, Strzelczyk A, Rusu P, Bendner G, Wiese S, Diella F, et al. Progressive postnatal motoneuron loss in mice lacking GDF-15. J Neurosci 2009. Oct 28;29(43):13640–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hellstrom Erkenstam N, Smith PL, Fleiss B, Nair S, Svedin P, Wang W, et al. Temporal Characterization of Microglia/Macrophage Phenotypes in a Mouse Model of Neonatal Hypoxic-Ischemic Brain Injury. Front Cell Neurosci 2016;10:286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Herrmann JR, Kochanek PM, Vagni VA, Janesko-Feldman K, Stezoski J, Gorse K, et al. FGF21 modulates hippocampal cold-shock proteins and CA2-subregion proteins in neonatal mice with hypoxia-ischemia. Pediatr Res 2023. May 16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Xia M, Zhang Q, Zhang Y, Li R, Zhao T, Chen L, et al. Growth Differentiation Factor 15 Regulates Oxidative Stress-Dependent Ferroptosis Post Spinal Cord Injury by Stabilizing the p62-Keap1-Nrf2 Signaling Pathway. Front Aging Neurosci 2022;14:905115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Machado V, Haas SJ, von Bohlen Und Halbach O, Wree A, Krieglstein K, Unsicker K, et al. Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson’s disease. Neurobiol Dis 2016. Apr;88:1–15. [DOI] [PubMed] [Google Scholar]
  • 39.Sabatini PV, Frikke-Schmidt H, Arthurs J, Gordian D, Patel A, Rupp AC, et al. GFRAL-expressing neurons suppress food intake via aversive pathways. Proceedings of the National Academy of Sciences of the United States of America. 2021. Feb 23;118(8). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Fichtner K, Kalwa H, Lin MM, Gong Y, Muglitz A, Kluge M, et al. GFRAL Is Widely Distributed in the Brain and Peripheral Tissues of Mice. Nutrients. 2024. Mar 4;16(5). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Engstrom Ruud L, Font-Girones F, Zajdel J, Kern L, Teixidor-Deulofeu J, Manneras-Holm L, et al. Activation of GFRAL(+) neurons induces hypothermia and glucoregulatory responses associated with nausea and torpor. Cell Rep 2024. Apr 23;43(4):113960. [DOI] [PubMed] [Google Scholar]
  • 42.Jha RM, Rajasundaram D, Sneiderman C, Schlegel BT, O’Brien C, Xiong Z, et al. A single-cell atlas deconstructs heterogeneity across multiple models in murine traumatic brain injury and identifies novel cell-specific targets. Neuron 2024. Jul 11. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analyzed during this study are included in this published article. Further inquiries can be directed to the corresponding author.

RESOURCES